Coronary Artery Disease in End-Stage Renal Disease
- 1 July 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (7) , 1927-1939
- https://doi.org/10.1097/01.asn.0000069165.79509.42
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Cardiac Valve Calcification as an Important Predictor for All-Cause Mortality and Cardiovascular Mortality in Long-Term Peritoneal Dialysis PatientsJournal of the American Society of Nephrology, 2003
- Inflammation in atherosclerosisNature, 2002
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Stabilization of atherosclerotic plaques: New mechanisms and clinical targetsNature Medicine, 2002
- Opinion: How Should Hyperphosphatemia Be Managed in Dialysis Patients?Seminars in Dialysis, 2002
- PPARγ Ligand Inhibits Osteopontin Gene Expression Through Interference With Binding of Nuclear Factors to A/T-Rich Sequence in THP-1 CellsCirculation Research, 2002
- Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal DiseaseHypertension, 2001
- Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cellsCardiovascular Research, 2001
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progressionThe American Journal of Cardiology, 1995